Resistance to Cetuximab in EGFR-Overexpressing Esophageal Squamous Cell Carcinoma Xenografts Due to FGFR2 Amplification and Overexpression

RAS/PI3K Crosstalk and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma

(2014) T. Rampias et al.   CLINICAL CANCER RESEARCH

Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy

(2012) B. M. Stiles et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Activated O2^|^bull;^|^minus; and H2O2 Mediated Cell Survival in SU11274-Treated Non-Small-Cell Lung Cancer A549 Cells via c-Met^|^ndash;PI3K^|^ndash;Akt and c-Met^|^ndash;Grb2/SOS^|^ndash;Ras^|^ndash;p38 Pathways

(2012) Ying Liu et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor

(2012) V. Guagnano et al.   Cancer Discovery

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?

(2010) H. Pohl et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

(2009) F Kullmann et al.   BRITISH JOURNAL OF CANCER

The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation

(2009) William E Tidyman et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Interaction of antibodies with ErbB receptor extracellular regions

(2008) Karl R. Schmitz et al.   EXPERIMENTAL CELL RESEARCH

ErbB-directed immunotherapy: Antibodies in current practice and promising new agents

(2008) Elza Friedländer et al.   IMMUNOLOGY LETTERS

Ras oncogenes: split personalities

(2008) Antoine E. Karnoub et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

(2008) D L Wheeler et al.   ONCOGENE